Renewal Of Marketing Authorisation, The Mutual Recognition Secondoprocedura, Of The Medicinal Product For Human Use "sildenafil Thinks Pharma», Resulting In A Review Printed.

Original Language Title: Rinnovo dell'autorizzazione all'immissione in commercio, secondoprocedura di mutuo riconoscimento, del medicinale per uso umano«Sildenafil Pensa Pharma», con conseguente modifica stampati.

Read the untranslated law here: http://www.gazzettaufficiale.it/atto/serie_generale/caricaArticoloDefault/originario?atto.dataPubblicazioneGazzetta=2015-05-05&atto.codiceRedazionale=15A03275&elenco30giorni=false&atto.tipoProvvedimento=DECRETO

Retrieved April 14, 2015 108/2015 # PV of Medicine determines: SILDENAFIL THINKS PHARMA.
Packaging: 041063 013 «25 mg chewable» 4 tablets in PVC/PCTFE-AL;
041063 025 «25 mg chewable» 8 tablets in PVC/PCTFE-AL;
«12» 041063 037 25 mg chewable tablets in PVC/PCTFE-AL;
041063 049 «50 mg chewable» 4 tablets in PVC/PCTFE-AL;
041063 052 «50 mg chewable» 8 tablets in PVC/PCTFE-AL;
«041063 064 12 ' 50 mg chewable tablets in PVC/PCTFE-AL;
041063 076 «100 mg chewable» 4 tablets in PVC/PCTFE-AL;
041063 088 «100 mg chewable» 8 tablets in PVC/PCTFE-AL;
«041063 090 100 mg chewable» 12 tablets in PVC/PCTFE-AL.
A.I.C. holder: think Pharma S.p.a.
Mutual recognition procedure: 0338/001-003/PT/H/R/001.
Expiring on November 30, 2014 it is renewed, with unlimited validity, the marketing authorisation subject to amendment of the summary of product characteristics, package leaflet and labelling and on condition that, on the date of entry into force of this determination, the requirements of quality, safety and efficacy are still present.
Changes must be made immediately to the summary of the product characteristics as per the package leaflet and labelling no later than six months after its publication in the Official Gazette of the Italian Republic of this determination.
In accordance with art. 80, paragraphs 1 and 3, of Legislative Decree No 219 April 24, 2006 and s leaflet and labels must be written in Italian and, limited to medicinal products marketed in the province of Bolzano, in German. The holder of the A.I.C. avails itself of the complementary use of foreign languages, must give prior notice to the AIFA and keep available the certified translation of German texts and/or in another foreign language. In case of non-compliance with the provisions on the labelling and package leaflet shall apply sanctions under art. 82 of the Decree.
Both lots already products as of the date of publication in the official journal of the Italian Republic of this determination that the batches produced during the period referred to in art. 2, paragraph 2, of the aforementioned determination, which did not indicate the changes authorized, can be kept on the market until the expiration date printed on the label of the medicine.
This determination takes effect from the day following that of its publication in the official journal of the Italian Republic and will be notified to the company holder of the marketing authorisation of the medicinal product.